COVID-19: angiotensin II in development of lung immunothrombosis and vasculitis mimics - Author's reply
Lancet Rheumatol
.
2021 May;3(5):e326.
doi: 10.1016/S2665-9913(21)00065-5.
Epub 2021 Mar 17.
Authors
Dennis McGonagle
1
2
,
Charlie Bridgewood
1
,
Athimalaipet V Ramanan
3
,
James F M Meaney
4
,
Abdulla Watad
1
5
Affiliations
1
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
2
National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, Leeds, UK.
3
University Hospitals Bristol NHS Foundation Trust & Bristol Medical School, University of Bristol, Bristol, UK.
4
Department of Radiology, St James Hospital and The Thomas Mitchell Centre for Advanced Medical Imaging, Trinity College Dublin, Dublin, Ireland.
5
Department of Medicine B, Rheumatology Unit, Sheba Medical Center, Tel Aviv, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
PMID:
33754145
PMCID:
PMC7969146
DOI:
10.1016/S2665-9913(21)00065-5
No abstract available